A New York federal judge has upheld a partial jury verdict against Quincy Bioscience, the makers of Prevagen, a dietary supplement that claims to improve memory loss. The ruling by U.S. District Judge Louis L. Stanton affirms the authority of the New York Attorney General’s office to proceed under New York Executive Law §63(12) in cases involving fraudulent practices. The verdict from May found that the company had engaged in deceptive practices under this law, highlighting the AG’s capacity to regulate and investigate repeated acts of fraud.
This decision emphasizes the regulatory powers granted to state attorney generals in overseeing consumer protection issues. For more detailed coverage, the original article can be read here.